Hepatitis B surface antigen reduction as a result of switching from long-term entecavir administration to tenofovir.
Tamaki N, Kurosaki M, Kirino S, Yamashita K, Osawa L, Sekiguchi S, Hayakawa Y, Wang W, Okada M, Higuchi M, Takaura K, Maeyashiki C, Kaneko S, Yasui Y, Tsuchiya K, Nakanishi H, Itakura J, Takahashi Y, Enomoto N, Izumi N.
Tamaki N, et al. Among authors: osawa l.
JGH Open. 2019 Oct 24;4(3):429-432. doi: 10.1002/jgh3.12273. eCollection 2020 Jun.
JGH Open. 2019.
PMID: 32514449
Free PMC article.